Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity.
Vincent-Salomon A, Gruel N, Lucchesi C, MacGrogan G, Dendale R, Sigal-Zafrani B, Longy M, Raynal V, Pierron G, de Mascarel I, Taris C, Stoppa-Lyonnet D, Pierga JY, Salmon R, Sastre-Garau X, Fourquet A, Delattre O, de Cremoux P, Aurias A. Vincent-Salomon A, et al. Among authors: de mascarel i, de cremoux p. Breast Cancer Res. 2007;9(2):R24. doi: 10.1186/bcr1666. Breast Cancer Res. 2007. PMID: 17417968 Free PMC article.
Tumor aromatase expression as a prognostic factor for local control in young breast cancer patients after breast-conserving treatment.
Bollet MA, Savignoni A, De Koning L, Tran-Perennou C, Barbaroux C, Degeorges A, Sigal-Zafrani B, Almouzni G, Cottu P, Salmon R, Servant N, Fourquet A, de Cremoux P. Bollet MA, et al. Among authors: de koning l, de cremoux p. Breast Cancer Res. 2009;11(4):R54. doi: 10.1186/bcr2343. Epub 2009 Jul 28. Breast Cancer Res. 2009. PMID: 19638208 Free PMC article.
Molecular profiling of patient-derived breast cancer xenografts.
Reyal F, Guyader C, Decraene C, Lucchesi C, Auger N, Assayag F, De Plater L, Gentien D, Poupon MF, Cottu P, De Cremoux P, Gestraud P, Vincent-Salomon A, Fontaine JJ, Roman-Roman S, Delattre O, Decaudin D, Marangoni E. Reyal F, et al. Among authors: de plater l, de cremoux p. Breast Cancer Res. 2012 Jan 16;14(1):R11. doi: 10.1186/bcr3095. Breast Cancer Res. 2012. PMID: 22247967 Free PMC article.
No significant predictive value of c-erbB-2 or p53 expression regarding sensitivity to primary chemotherapy or radiotherapy in breast cancer.
Rozan S, Vincent-Salomon A, Zafrani B, Validire P, De Cremoux P, Bernoux A, Nieruchalski M, Fourquet A, Clough K, Dieras V, Pouillart P, Sastre-Garau X. Rozan S, et al. Among authors: de cremoux p. Int J Cancer. 1998 Feb 20;79(1):27-33. doi: 10.1002/(sici)1097-0215(19980220)79:1<27::aid-ijc6>3.0.co;2-y. Int J Cancer. 1998. PMID: 9495354
p53 mutation as a genetic trait of typical medullary breast carcinoma.
de Cremoux P, Salomon AV, Liva S, Dendale R, Bouchind'homme B, Martin E, Sastre-Garau X, Magdelenat H, Fourquet A, Soussi T. de Cremoux P, et al. J Natl Cancer Inst. 1999 Apr 7;91(7):641-3. doi: 10.1093/jnci/91.7.641. J Natl Cancer Inst. 1999. PMID: 10203285 No abstract available.
Medullary breast carcinoma: prognostic implications of p53 expression.
Dendale R, Vincent-Salomon A, Mouret-Fourme E, Savignoni A, Medioni J, Campana F, Vilcoq JR, de la Rochefordière A, Soussi T, Asselain B, de Cremoux P, Fourquet A. Dendale R, et al. Among authors: de la rochefordiere a, de cremoux p. Int J Biol Markers. 2003 Apr-Jun;18(2):99-105. doi: 10.5301/jbm.2008.1279. Int J Biol Markers. 2003. PMID: 12841678 Free article.
A new model of patient tumor-derived breast cancer xenografts for preclinical assays.
Marangoni E, Vincent-Salomon A, Auger N, Degeorges A, Assayag F, de Cremoux P, de Plater L, Guyader C, De Pinieux G, Judde JG, Rebucci M, Tran-Perennou C, Sastre-Garau X, Sigal-Zafrani B, Delattre O, Diéras V, Poupon MF. Marangoni E, et al. Among authors: de pinieux g, de plater l, de cremoux p. Clin Cancer Res. 2007 Jul 1;13(13):3989-98. doi: 10.1158/1078-0432.CCR-07-0078. Clin Cancer Res. 2007. PMID: 17606733
168 results